These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9817495)

  • 1. High perimeter impedance defibrillation electrodes reduce skin burns in transthoracic cardioversion.
    Garcia LA; Pagan-Carlo LA; Stone MS; Kerber RE
    Am J Cardiol; 1998 Nov; 82(9):1125-7, A9. PubMed ID: 9817495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impedance-gradient electrode reduces skin irritation induced by transthoracic defibrillation.
    Meyer PF; Gadsby PD; Van Sickle D; Schoenlein WE; Foster KS; Graber GP
    Med Biol Eng Comput; 2005 Mar; 43(2):225-9. PubMed ID: 15865132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature and determinants of skin "burns" after transthoracic cardioversion.
    Pagan-Carlo LA; Stone MS; Kerber RE
    Am J Cardiol; 1997 Mar; 79(5):689-91. PubMed ID: 9068538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of the effect of biphasic or monophasic waveform on the incidence and severity of cutaneous burns following external direct current cardioversion.
    Ambler JJ; Deakin CD
    Resuscitation; 2006 Dec; 71(3):293-300. PubMed ID: 16996194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances.
    Kerber RE
    Am J Cardiol; 1996 Oct; 78(8A):22-6. PubMed ID: 8903272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental evaluation and initial clinical application of new self-adhesive defibrillation electrodes.
    Kerber RE; Martins JB; Ferguson DW; Jensen SR; Parke JD; Kieso R; Melton J
    Int J Cardiol; 1985 May; 8(1):57-66. PubMed ID: 3997292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new defibrillation pathway: tongue-epigastric/tongue-apex route. II. Impedance characteristics in human subjects.
    Kerber RE; Klein S; Kouba C; Aronson A
    J Am Coll Cardiol; 1984 Aug; 4(2):253-8. PubMed ID: 6736465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transesophageal low-energy synchronous cardioversion of atrial flutter/fibrillation in the dog.
    Yamanouchi Y; Kumagai K; Tashiro N; Hiroki T; Arakawa K
    Am Heart J; 1992 Feb; 123(2):417-20. PubMed ID: 1736579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burn progression secondary to cardioversion.
    Kennedy JM; Goldie C; Nickerson D
    J Burn Care Res; 2011; 32(4):e143-5. PubMed ID: 21593681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of current density distribution under electrodes for external defibrillation.
    Krasteva VT; Papazov SP
    Biomed Eng Online; 2002 Dec; 1():7. PubMed ID: 12537593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transesophageal cardioversion of atrial flutter and atrial fibrillation using an electric balloon electrode system.
    Zheng F; Qi X; Liu H; Kang N
    Chin Med J (Engl); 2003 Sep; 116(9):1325-8. PubMed ID: 14527358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and severity of cutaneous burns following external DC cardioversion.
    Ambler JJ; Sado DM; Zideman DA; Deakin CD
    Resuscitation; 2004 Jun; 61(3):281-8. PubMed ID: 15172706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possibilities for predictive measurement of the transthoracic impedance in defibrillation.
    Krasteva V; Hatib FA; Trendafilova E; Daskalov I
    J Med Eng Technol; 2001; 25(5):195-200. PubMed ID: 11695659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electric ablation and intracardiac cardioversion in the treatment of atrial arrhythmias].
    Kaźmierczak J; Gil R; Kornacewicz-Jach Z
    Kardiol Pol; 1991; 35(9):197-200. PubMed ID: 1753568
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of the esophageal electric countershock].
    Lukoshevichiute AI; Pechiulene IR
    Kardiologiia; 1978 Apr; 18(4):12-20. PubMed ID: 671956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidents of cutaneous alteration secondary to external electrical cardioversion].
    Alconero Camarero AR; Casaus Pérez M; Gutiérrez Caloca N
    Enferm Intensiva; 2006; 17(4):163-72. PubMed ID: 17194414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis.
    Berger M; Schweitzer P
    Am J Cardiol; 1998 Dec; 82(12):1545-7, A8. PubMed ID: 9874066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study].
    Bugán V; Renker B; Brunclík P; Baraniková D; Augustín E
    Vnitr Lek; 1994 Apr; 40(4):219-22. PubMed ID: 8184582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of paddle-electrode location and size on success of cardioversion.
    Ewy GA
    N Engl J Med; 1982 Jan; 306(3):174-5. PubMed ID: 7054666
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated.
    Densèm CG
    Am J Cardiol; 1999 Jan; 83(1):140-1. PubMed ID: 10073808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.